MVM Life Science Partners is a leading Venture Capital firm that invests in technologies and products for the life science and healthcare markets. MVM has teams in London and Boston.

Read more about MVM

19th July 2010
Cara Therapeutics Secures $15 million Series D Financing to Continue Clinical Development of CR845
Cara Therapeutics, Inc. announces the close of its Series D financing of $15 million
Read this article

3rd June 2010
PregLem Announces Additional Positive Phase III Results for Esmya
PregLem, a biopharmaceutical company focused on women’s reproductive medicine, announces positive Phase III data from its second pivotal study for Esmya (TM)
Read this article